From the Guidelines
The patient's blood test results indicate mild anemia and leukopenia, which may require further evaluation and potential treatment with transfusions, iron supplements, or other interventions to manage symptoms and prevent complications, as suggested by the NCCN guidelines for supportive care in patients with myeloproliferative neoplasms 1. The patient should be informed that their low hemoglobin and hematocrit levels, as well as their low white blood cell count, may increase their risk of infections, bleeding, and other complications, and that we will need to closely monitor their condition and adjust their treatment plan accordingly, considering options such as RBC transfusions for symptomatic anemia, antibiotic prophylaxis for recurrent infections, and hematopoietic growth factor therapy to manage neutropenia, as recommended by the NCCN guidelines 1.
From the Research
Patient Information
- Your blood test results show a white blood cell (WBC) count of 2.23, which is lower than the normal range, indicating leukopenia 2, 3.
- Your red blood cell (RBC) count is 4.12, hemoglobin is 11.6, and hematocrit is 35.5, which may indicate anemia, and it is essential to determine the underlying cause of these findings 4, 5.